Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07657832
Active, not recruiting Observational

Stone Heterogeneity Index and Shock Wave Lithotripsy Outcomes in Pediatrics

NCT07657832 · tracked via the Priya Life Science Egypt tracker
Sponsor
Mansoura University
Phase
Observational
Started
2025-03-04
Last updated
2026-06-18

Condition(s) studied

Stone Heterogeneity IndexShock Wave Lithotripsy

Study summary

To assess the role of SHI in SWL outcomes for upper urinary tract calculi in pediatric population.

Eligibility

Sex
ALL
Min age
1 Year
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 1year and 18 years. * Both ureteric stone with size 5 mm-10 mm and renal stone with size 10 mm-20 mm. * Only those patients who had NCCT available for review after at least 3 months from the last session of SWL will be included in the study. Exclusion Criteria: * Patients \>18 years of age. * Subjects suffering from active urinary tract infection. * Multiple renal calculi. * Presence of anatomical renal abnormalities that may affect stone clearance and renal insufficiency.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mansoura University Al Mansurah Mansoura

More Mansoura University trials in Egypt

Evaluation of Dentoalveolar Changes of Clear Aligners Versus Fixed Orthodontic Appliances on Skeletal Class I Non-extraction Patients With Dental Crowding Active, not recruiting
Effect of AV Distraction and Acuapoint Stimulation in Pediatric Extraction on Pain and Anxiety Enrolling by invitation
Impact of a Mobile Application-Based Medication Reminder on Treatment Adherence Among Patients With Chronic Diseases and Memory Impairment: A Nursing Leadership Perspective Recruiting
Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women Recruiting
Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07657832 on ClinicalTrials.gov ↗ ← All trials in Egypt